vs
ADVANCE AUTO PARTS INC（AAP）与Solventum（SOLV）财务数据对比。点击上方公司名可切换其他公司
Solventum的季度营收约是ADVANCE AUTO PARTS INC的1.0倍（$2.0B vs $2.0B），Solventum净利率更高（3.2% vs 0.3%，领先2.8%），ADVANCE AUTO PARTS INC同比增速更快（130.1% vs -3.7%），Solventum自由现金流更多（$32.0M vs $-21.0M），过去两年Solventum的营收复合增速更高（-0.4% vs -15.7%）
Advance Auto Parts是美国知名汽车售后零部件供应商，总部位于北卡罗来纳州罗利市，业务覆盖专业维修安装服务商与汽车 DIY 爱好者两大客群，可为不同需求的用户提供适配的汽车零配件产品及相关服务。
Solventum是一家总部位于美国的医疗健康企业，于2024年4月1日正式从全球知名多元化工业集团3M分拆后独立运营，继承了原3M旗下医疗板块的技术积累与业务资源，面向全球市场提供专业医疗相关产品及服务。
AAP vs SOLV — 直观对比
营收规模更大
SOLV
是对方的1.0倍
$2.0B
营收增速更快
AAP
高出133.8%
-3.7%
净利率更高
SOLV
高出2.8%
0.3%
自由现金流更多
SOLV
多$53.0M
$-21.0M
两年增速更快
SOLV
近两年复合增速
-15.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.0B | $2.0B |
| 净利润 | $6.0M | $63.0M |
| 毛利率 | 44.1% | 51.4% |
| 营业利润率 | 2.2% | 6.3% |
| 净利率 | 0.3% | 3.2% |
| 营收同比 | 130.1% | -3.7% |
| 净利润同比 | 101.4% | 103.2% |
| 每股收益（稀释后） | $0.10 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AAPSOLV
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $2.0B | ||
| Q3 25 | $2.0B | $2.1B | ||
| Q2 25 | $2.6B | $2.2B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | $2.1B | $2.1B | ||
| Q3 24 | $2.2B | $2.1B | ||
| Q2 24 | $2.8B | $2.1B |
净利润AAPSOLV
| Q1 26 | $6.0M | — | ||
| Q4 25 | $-1.0M | $63.0M | ||
| Q3 25 | $15.0M | $1.3B | ||
| Q2 25 | $24.0M | $90.0M | ||
| Q1 25 | — | $137.0M | ||
| Q4 24 | $-6.0M | $31.0M | ||
| Q3 24 | $45.0M | $122.0M | ||
| Q2 24 | $40.0M | $89.0M |
毛利率AAPSOLV
| Q1 26 | 44.1% | — | ||
| Q4 25 | 43.3% | 51.4% | ||
| Q3 25 | 43.5% | 54.2% | ||
| Q2 25 | 42.9% | 54.4% | ||
| Q1 25 | — | 53.8% | ||
| Q4 24 | 42.3% | 53.9% | ||
| Q3 24 | 43.6% | 56.0% | ||
| Q2 24 | 43.4% | 54.6% |
营业利润率AAPSOLV
| Q1 26 | 2.2% | — | ||
| Q4 25 | 1.1% | 6.3% | ||
| Q3 25 | 1.1% | 80.6% | ||
| Q2 25 | -5.1% | 9.9% | ||
| Q1 25 | — | 7.3% | ||
| Q4 24 | — | 6.6% | ||
| Q3 24 | 2.5% | 13.2% | ||
| Q2 24 | 1.9% | 11.7% |
净利率AAPSOLV
| Q1 26 | 0.3% | — | ||
| Q4 25 | -0.0% | 3.2% | ||
| Q3 25 | 0.7% | 60.4% | ||
| Q2 25 | 0.9% | 4.2% | ||
| Q1 25 | — | 6.6% | ||
| Q4 24 | -0.3% | 1.5% | ||
| Q3 24 | 2.1% | 5.9% | ||
| Q2 24 | 1.4% | 4.3% |
每股收益（稀释后）AAPSOLV
| Q1 26 | $0.10 | — | ||
| Q4 25 | $-0.02 | $0.37 | ||
| Q3 25 | $0.25 | $7.22 | ||
| Q2 25 | $0.40 | $0.51 | ||
| Q1 25 | — | $0.78 | ||
| Q4 24 | $-0.10 | $0.18 | ||
| Q3 24 | $0.75 | $0.70 | ||
| Q2 24 | $0.67 | $0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.1B | $878.0M |
| 总债务越低越好 | $3.4B | $5.0B |
| 股东权益账面价值 | $2.2B | $5.0B |
| 总资产 | $11.8B | $14.3B |
| 负债/权益比越低杠杆越低 | 1.55× | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资AAPSOLV
| Q1 26 | $3.1B | — | ||
| Q4 25 | $3.2B | $878.0M | ||
| Q3 25 | $1.7B | $1.6B | ||
| Q2 25 | $1.7B | $492.0M | ||
| Q1 25 | — | $534.0M | ||
| Q4 24 | $464.5M | $762.0M | ||
| Q3 24 | $479.4M | $772.0M | ||
| Q2 24 | $451.0M | $897.0M |
总债务AAPSOLV
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.4B | $5.0B | ||
| Q3 25 | $1.8B | $5.1B | ||
| Q2 25 | $1.8B | $7.8B | ||
| Q1 25 | — | $7.9B | ||
| Q4 24 | $1.8B | $8.0B | ||
| Q3 24 | $1.8B | $8.1B | ||
| Q2 24 | $1.8B | $8.3B |
股东权益AAPSOLV
| Q1 26 | $2.2B | — | ||
| Q4 25 | $2.2B | $5.0B | ||
| Q3 25 | $2.2B | $5.0B | ||
| Q2 25 | $2.2B | $3.6B | ||
| Q1 25 | — | $3.3B | ||
| Q4 24 | $2.6B | $3.0B | ||
| Q3 24 | $2.6B | $3.2B | ||
| Q2 24 | $2.6B | $2.9B |
总资产AAPSOLV
| Q1 26 | $11.8B | — | ||
| Q4 25 | $12.1B | $14.3B | ||
| Q3 25 | $10.5B | $14.0B | ||
| Q2 25 | $10.6B | $15.1B | ||
| Q1 25 | — | $14.5B | ||
| Q4 24 | $12.5B | $14.5B | ||
| Q3 24 | $12.3B | $14.7B | ||
| Q2 24 | $12.2B | $14.6B |
负债/权益比AAPSOLV
| Q1 26 | 1.55× | — | ||
| Q4 25 | 1.55× | 1.00× | ||
| Q3 25 | 0.81× | 1.03× | ||
| Q2 25 | 0.81× | 2.14× | ||
| Q1 25 | — | 2.43× | ||
| Q4 24 | 0.69× | 2.71× | ||
| Q3 24 | 0.69× | 2.54× | ||
| Q2 24 | 0.70× | 2.90× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $72.0M | $95.0M |
| 自由现金流经营现金流 - 资本支出 | $-21.0M | $32.0M |
| 自由现金流率自由现金流/营收 | -1.1% | 1.6% |
| 资本支出强度资本支出/营收 | 4.7% | 3.2% |
| 现金转化率经营现金流/净利润 | 12.00× | 1.51× |
| 过去12个月自由现金流最近4个季度 | $-298.0M | $-10.0M |
8季度趋势，按日历期对齐
经营现金流AAPSOLV
| Q1 26 | $72.0M | — | ||
| Q4 25 | $-12.0M | $95.0M | ||
| Q3 25 | $50.0M | $76.0M | ||
| Q2 25 | $-156.0M | $169.0M | ||
| Q1 25 | — | $29.0M | ||
| Q4 24 | $70.0M | $219.0M | ||
| Q3 24 | $85.0M | $169.0M | ||
| Q2 24 | $3.0M | $355.0M |
自由现金流AAPSOLV
| Q1 26 | $-21.0M | — | ||
| Q4 25 | $-76.0M | $32.0M | ||
| Q3 25 | $-3.0M | $-21.0M | ||
| Q2 25 | $-198.0M | $59.0M | ||
| Q1 25 | — | $-80.0M | ||
| Q4 24 | $27.0M | $92.0M | ||
| Q3 24 | $44.0M | $76.0M | ||
| Q2 24 | $-43.0M | $297.0M |
自由现金流率AAPSOLV
| Q1 26 | -1.1% | — | ||
| Q4 25 | -3.7% | 1.6% | ||
| Q3 25 | -0.1% | -1.0% | ||
| Q2 25 | -7.7% | 2.7% | ||
| Q1 25 | — | -3.9% | ||
| Q4 24 | 1.3% | 4.4% | ||
| Q3 24 | 2.0% | 3.7% | ||
| Q2 24 | -1.6% | 14.3% |
资本支出强度AAPSOLV
| Q1 26 | 4.7% | — | ||
| Q4 25 | 3.1% | 3.2% | ||
| Q3 25 | 2.6% | 4.6% | ||
| Q2 25 | 1.6% | 5.1% | ||
| Q1 25 | — | 5.3% | ||
| Q4 24 | 2.0% | 6.1% | ||
| Q3 24 | 1.9% | 4.5% | ||
| Q2 24 | 1.7% | 2.8% |
现金转化率AAPSOLV
| Q1 26 | 12.00× | — | ||
| Q4 25 | — | 1.51× | ||
| Q3 25 | 3.33× | 0.06× | ||
| Q2 25 | -6.50× | 1.88× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 7.06× | ||
| Q3 24 | 1.89× | 1.39× | ||
| Q2 24 | 0.07× | 3.99× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AAP
暂无分部数据
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
